Copyright
©The Author(s) 2021.
World J Gastrointest Surg. May 27, 2021; 13(5): 476-492
Published online May 27, 2021. doi: 10.4240/wjgs.v13.i5.476
Published online May 27, 2021. doi: 10.4240/wjgs.v13.i5.476
Figure 3 Liver resection, when comparing to transarterial chemoembolization, can provide a better long-term outcome for selected hepatocellular carcinoma ≥ 10 cm.
A: Overall survival; B: Hepatocellular carcinoma (HCC)-specific survival. Estimated with inverse-probability of treatment weighting (IPTW). TACE: Transarterial chemoembolization.
- Citation: Lee CW, Yu MC, Wang CC, Lee WC, Tsai HI, Kuan FC, Chen CW, Hsieh YC, Chen HY. Liver resection for hepatocellular carcinoma larger than 10 cm: A multi-institution long-term observational study. World J Gastrointest Surg 2021; 13(5): 476-492
- URL: https://www.wjgnet.com/1948-9366/full/v13/i5/476.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i5.476